{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:17:05Z","timestamp":1772849825714,"version":"3.50.1"},"reference-count":83,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2016.00056","type":"journal-article","created":{"date-parts":[[2016,5,30]],"date-time":"2016-05-30T13:20:14Z","timestamp":1464614414000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["History of Nephrotic Syndrome and Evolution of its Treatment"],"prefix":"10.3389","volume":"4","author":[{"given":"Abhijeet","family":"Pal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick","family":"Kaskel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,5,30]]},"reference":[{"key":"B1","volume-title":"The Medical Works of Hippocrates: A New Translation from the Original Greek","author":"Chadwick","year":"1950"},{"key":"B2","first-page":"S5","article-title":"Five hundred years of the nephrotic syndrome: 1484-1984","volume":"54","author":"Cameron","year":"1985","journal-title":"Ulster Med J"},{"key":"B3","volume-title":"Liber de Aegritudinibus Infantium","author":"Roelans","year":"1484"},{"issue":"2\u20133","key":"B4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000063768","article-title":"The origins and development of the concept of a \u201cnephrotic syndrome\u201d","volume":"22","author":"Cameron","year":"2002","journal-title":"Am J Nephrol"},{"key":"B5","first-page":"659","article-title":"Anasarca puerorum","volume-title":"Paedioatreia Pract Curationem Puerorumque Morborum Puerilium etc","author":"Zwinger","year":"1974"},{"key":"B6","volume-title":"De Sedibus et Causis Morborum. Epist XVIII","author":"Morgagni","year":"1760"},{"key":"B7","author":"Heberden","year":"1802","journal-title":"Commentaries on the History and Cure of Diseases"},{"key":"B8","author":"Cotugno","year":"1770","journal-title":"De ischiade nervosa commentarius"},{"key":"B9","first-page":"3","article-title":"The nephrotic syndrome: A historical review","volume-title":"The Nephrotic Syndrome","author":"Cameron","year":"1988"},{"key":"B10","first-page":"194","article-title":"On the presence of the red matter and serum of blood in the urine of dropsy, which has not originated from scarlet fever","volume":"3","author":"Wells","year":"1812","journal-title":"Tr Soc Improv Med Clin Knowl"},{"key":"B11","author":"Bright","year":"1827","journal-title":"Reports of Medical Cases"},{"key":"B12","first-page":"262","article-title":"Observations on the variety of dropsy which depends on diseased kidney","volume":"32","author":"Christison","year":"1929","journal-title":"Edin Med Surg J"},{"key":"B13","first-page":"274","article-title":"On the cause of the milky and whey-like appearances sometimes observed in the blood","volume":"33","author":"Christison","year":"1830","journal-title":"Edin Med Surg J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/095952874602900102","article-title":"On the minute anatomy and pathology of Bright\u2019s disease of the kidney, and on the relation to the renal disease to those diseases of the liver, heart and arteries with which it is associated","volume":"29","author":"Johnson","year":"1846","journal-title":"Med Chir Trans"},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.5962\/bhl.title.32770","volume-title":"Cellular Pathology as Based upon Physiological and Pathological Histology","author":"Virchow","year":"1863"},{"key":"B16","first-page":"634","volume-title":"Handbuch Der Pathologischen Anatomie","author":"Klebs","year":"1870"},{"key":"B17","first-page":"64","article-title":"Morbus Brightii","volume":"9","author":"M\u00fcller","year":"1905","journal-title":"Verh Dtsch Ges Path"},{"issue":"4","key":"B18","doi-asserted-by":"publisher","first-page":"751","DOI":"10.7326\/0003-4819-49-4-751","article-title":"The nephrotic syndrome in adults: a common disorder with many causes","volume":"49","author":"Kark","year":"1958","journal-title":"Ann Intern Med"},{"issue":"3\u20134","key":"B19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1017\/CBO9781107415324.004","article-title":"The introduction of renal biopsy into nephrology from 1901 to 1961: a paradigm of the forming of nephrology by technology","volume":"17","author":"Cameron","year":"1997","journal-title":"Am J Nephrol"},{"issue":"2","key":"B20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0031-3955(16)32565-2","article-title":"The nephrotic syndrome","volume":"18","author":"Arneil","year":"1971","journal-title":"Pediatr Clin North Am"},{"issue":"3","key":"B21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0021-9258(18)74790-X","article-title":"The chemistry of crystalline substances isolated from the suprarenal gland","volume":"114","author":"Mason","year":"1936","journal-title":"J Biol Chem"},{"issue":"22","key":"B22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1056\/NEJM195006012422205","article-title":"The clinical usefulness of ACTH and cortisone","volume":"242","author":"Thorn","year":"1950","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0021-9258(17)41405-0","article-title":"Partial synthesis of pregnene-4-triol-17(beta), 20(beta), 21-dione-3,11 and pregnene-4-diol-17(beta), 21-trione-3,11,20 monoacetate","volume":"162","author":"Sarett","year":"1946","journal-title":"J Biol Chem"},{"issue":"2","key":"B24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0021-9258(18)72189-3","article-title":"Preparation and properties of pituitary adrenotropic hormone","volume":"149","author":"Sayers","year":"1943","journal-title":"J Biol Chem"},{"issue":"134","key":"B25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1136\/adc.27.134.322","article-title":"Cortisone treatment of nephrosis","volume":"27","author":"Arneil","year":"1952","journal-title":"Arch Dis Child"},{"issue":"141","key":"B26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1136\/adc.28.141.372","article-title":"A.C.T.H. in nephrosis","volume":"28","author":"Arneil","year":"1953","journal-title":"Arch Dis Child"},{"issue":"3","key":"B27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0039-128X(94)90033-7","article-title":"The discovery of the \u03b41,4-steroids, prednisone, and prednisolone at the Schering Corporation (USA)","volume":"59","author":"Nobile","year":"1994","journal-title":"Steroids"},{"issue":"12","key":"B28","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/0039-128X(92)90014-Z","article-title":"A history of significant steroid discoveries and developments originating at the Schering Corporation (USA) since 1948","volume":"57","author":"Herzog","year":"1992","journal-title":"Steroids"},{"issue":"5","key":"B29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/BF02903017","article-title":"Observations on prednisolone treated cases of nephrotic syndrome","volume":"25","author":"Chaudhuri","year":"1958","journal-title":"Indian J Pediatr"},{"issue":"99","key":"B30","first-page":"1728","article-title":"[Early results of prednisone therapy of nephrotic syndromes]","volume":"46","author":"Barbieri","year":"1955","journal-title":"Minerva Med"},{"issue":"4","key":"B31","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1542\/peds.73.4.497","article-title":"Minimal change nephrotic syndrome in children: deaths during the first 5 to 15 years\u2019 observation","volume":"73","author":"Barnett","year":"1984","journal-title":"Pediatrics"},{"issue":"2","key":"B32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ki.1978.23","article-title":"A Report of the International Study of Kidney Disease in Children. Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis","volume":"13","year":"1978","journal-title":"Kidney Int"},{"issue":"4","key":"B33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/s0022-3476(81)80760-3","article-title":"The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone","volume":"98","author":"A report of the International Study of Kidney Disease in Children","year":"1981","journal-title":"J Pediatr"},{"issue":"10","key":"B34","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.14842\/jpnjnephrol1959.21.10_1141","article-title":"International study of kidney disease in children","volume":"21","author":"Barnett","year":"1979","journal-title":"Jpn J Nephrol"},{"issue":"6","key":"B35","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ki.1981.209","article-title":"Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity","volume":"20","author":"Report","year":"1981","journal-title":"Kidney Int"},{"issue":"7660","key":"B36","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/S0140-6736(70)91905-7","article-title":"Pathology of the nephrotic syndrome in children","volume":"295","author":"Churg","year":"1970","journal-title":"Lancet"},{"issue":"7654","key":"B37","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0140-6736(70)91093-7","article-title":"Controlled trial of azathioprine in children with nephrotic syndrome","volume":"295","author":"Abramowicz","year":"1970","journal-title":"Lancet"},{"issue":"5","key":"B38","first-page":"498","article-title":"Use of combined hormone and mechlorethamine (nitrogen mustard) therapy in lipoid nephrosis","volume":"95","author":"West","year":"1958","journal-title":"AMA J Dis Child"},{"issue":"7887","key":"B39","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/S0140-6736(74)92073-X","article-title":"Long-term assessment of cyclophosphamide therapy for nephrosis in children","volume":"304","author":"Mcdonald","year":"1974","journal-title":"Lancet"},{"issue":"5","key":"B40","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S0272-6386(83)80094-8","article-title":"Nitrogen mustard therapy in children with frequent-relapsing nephrotic syndrome and steroid toxicity","volume":"2","author":"Schoeneman","year":"1983","journal-title":"Am J Kidney Dis"},{"issue":"14","key":"B41","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1056\/NEJM197609302951402","article-title":"Chlorambucil treatment of frequently relapsing nephrotic syndrome","volume":"295","author":"Grupe","year":"1976","journal-title":"N Engl J Med"},{"issue":"1","key":"B42","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/S0022-3476(88)80136-7","article-title":"Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome","volume":"112","author":"Ueda","year":"1988","journal-title":"J Pediatr"},{"issue":"3","key":"B43","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","article-title":"Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO","volume":"28","author":"Lombel","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"CD001533","DOI":"10.1002\/14651858.CD001533.pub5","article-title":"Corticosteroid therapy for nephrotic syndrome in children","volume":"3","author":"Hahn","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3 Pt 1","key":"B45","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/S0022-3476(80)80707-4","article-title":"Treatment of nephrotic syndrome with levamisole","volume":"96","author":"Tanphaichitr","year":"1980","journal-title":"J Pediatr"},{"issue":"11","key":"B46","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1023\/A:1008990919682","article-title":"From Norway to Novartis: cyclosporin from Tolypocladium inflatum in an open access bioprospecting regime","volume":"9","author":"Svarstad","year":"2000","journal-title":"Biodivers Conserv"},{"issue":"8104\u20135","key":"B47","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(78)91970-0","article-title":"Cyclosporin A in patients receiving renal allografts from cadaver donors","volume":"2","author":"Calne","year":"1978","journal-title":"Lancet"},{"issue":"6523","key":"B48","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1136\/bmj.292.6523.789","article-title":"Remission of idiopathic nephrotic syndrome after treatment with cyclosporin A","volume":"292","author":"Meyrier","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"4","key":"B49","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/BF00853590","article-title":"Cyclosporin in the treatment of idiopathic nephrotic syndrome in children","volume":"1","author":"Niaudet","year":"1987","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"B50","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/ki.1988.59","article-title":"Cyclosporine A induced remission of relapsing nephrotic syndrome in children","volume":"33","author":"Tejani","year":"1988","journal-title":"Kidney Int"},{"issue":"9","key":"B51","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.7164\/antibiotics.40.1256","article-title":"FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics","volume":"40","author":"Kino","year":"1987","journal-title":"J Antibiot (Tokyo)"},{"issue":"4","key":"B52","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/ndt\/17.4.655","article-title":"Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up","volume":"17","author":"Segarra","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"B53","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1093\/ndt\/12.11.2433","article-title":"Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome","volume":"12","author":"Schweda","year":"1997","journal-title":"Nephrol Dial Transplant"},{"issue":"8690","key":"B54","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/0140-6736(90)90471-G","article-title":"FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood","volume":"335","author":"McCauley","year":"1990","journal-title":"Lancet"},{"issue":"5","key":"B55","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00467-003-1098-0","article-title":"Effective tacrolimus treatment in a child suffering from severe nephrotic syndrome","volume":"18","author":"Pennesi","year":"2003","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"B56","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00467-003-1370-3","article-title":"Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome","volume":"19","author":"Loeffler","year":"2004","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"B57","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1093\/ndt\/gfi274","article-title":"Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus","volume":"21","author":"Sinha","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"B58","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s13312-013-0024-1","article-title":"50 years of nephrotic syndrome in children, and hereafter","volume":"50","author":"Srivastava","year":"2013","journal-title":"Indian Pediatr"},{"issue":"3","key":"B59","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s004670050047","article-title":"Remission of relapsing childhood nephrotic syndrome with mycophenolate mofetil","volume":"14","author":"Chandra","year":"2000","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"B60","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1053\/ajkd.1998.v31.pm9469489","article-title":"Successful mycophenolate mofetil treatment of glomerular disease","volume":"31","author":"Briggs","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"B61","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s00467-007-0617-9","article-title":"Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome","volume":"22","author":"Afzal","year":"2007","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"B62","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s00467-008-0899-6","article-title":"Mycophenolate mofetil versus cyclosporine for remission maintenance in nephrotic syndrome","volume":"23","author":"Dorresteijn","year":"2008","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"B63","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/kisup.2012.23","article-title":"KDIGO clinical practice guideline for glomerulonephritis","volume":"2","author":"Kidney Disease Improving Global Outcomes","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"6","key":"B64","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s00467-006-0427-5","article-title":"Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome?","volume":"22","author":"Smith","year":"2007","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"B65","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s00467-004-1434-z","article-title":"Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy","volume":"19","author":"Benz","year":"2004","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"B66","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1007\/s00467-005-2013-7","article-title":"Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome","volume":"20","author":"Nozu","year":"2005","journal-title":"Pediatr Nephrol"},{"issue":"18","key":"B67","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1056\/NEJMc055495","article-title":"Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment","volume":"354","author":"Pescovitz","year":"2006","journal-title":"N Engl J Med"},{"issue":"9950","key":"B68","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","article-title":"Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"384","author":"Iijima","year":"2014","journal-title":"Lancet"},{"issue":"3","key":"B69","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00467-007-0640-x","article-title":"Rituximab for refractory focal segmental glomerulosclerosis","volume":"23","author":"Nakayama","year":"2008","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"B70","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3265\/Nefrologia.pre2013.Jan.11871","article-title":"Treatment of idiopathic focal segmental glomerulosclerosis: options in the event of resistance to corticosteroids and calcineurin inhibitors","volume":"33","author":"Segarra-Medrano","year":"2013","journal-title":"Nefrologia"},{"issue":"2","key":"B71","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1399-3046.2008.00967.x","article-title":"Rituximab for post-transplant recurrences of FSGS","volume":"13","author":"Bayrakci","year":"2009","journal-title":"Pediatr Transplant"},{"issue":"85","key":"B72","doi-asserted-by":"publisher","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","article-title":"Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis","volume":"3","author":"Fornoni","year":"2011","journal-title":"Sci Transl Med"},{"issue":"63","key":"B73","first-page":"91","article-title":"Treatment of nephrotic syndrome with adrenocorticotropic hormone (ACTH)","volume":"12","author":"Bomback","year":"2011","journal-title":"Discov Med"},{"issue":"8","key":"B74","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1093\/ndt\/gfu069","article-title":"A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar\u00ae Gel) in nephrotic syndrome due to idiopathic membranous nephropathy","volume":"29","author":"Hladunewich","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"B75","doi-asserted-by":"publisher","first-page":"637","DOI":"10.5414\/CNP71637","article-title":"Case series of idiopathic membranous nephropathy with long-term beneficial effects of ACTH peptide 1-24","volume":"71","author":"Rauen","year":"2009","journal-title":"Clin Nephrol"},{"issue":"2","key":"B76","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1053\/j.ajkd.2005.10.016","article-title":"A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy","volume":"47","author":"Ponticelli","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"B77","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.2215\/CJN.02840313","article-title":"Treatment of idiopathic FSGS with adrenocorticotropic hormone gel","volume":"8","author":"Hogan","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"B78","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1093\/ndt\/gfh110","article-title":"ACTH-induced improvement in the nephrotic syndrome in patients with a variety of diagnoses","volume":"19","author":"Berg","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"1\u20133","key":"B79","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1159\/000368951","article-title":"Back to the future: therapies for idiopathic nephrotic syndrome","volume":"39","author":"Gibson","year":"2015","journal-title":"Blood Purif"},{"issue":"2","key":"B80","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/MNH.0000000000000204","article-title":"Human genetics of nephrotic syndrome and the quest for precision medicine","volume":"25","author":"Greka","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"20","key":"B81","doi-asserted-by":"publisher","first-page":"E2130","DOI":"10.1073\/pnas.1400699111","article-title":"Evolution of the primate trypanolytic factor APOL1","volume":"111","author":"Thomson","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"B82","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1681\/ASN.2013091017","article-title":"Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines","volume":"26","author":"Ma","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"B83","doi-asserted-by":"publisher","first-page":"e0125410","DOI":"10.1371\/journal.pone.0125410","article-title":"Copy number variation at the APOL1 locus","volume":"10","author":"Ruchi","year":"2015","journal-title":"PLoS One"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T21:07:02Z","timestamp":1656623222000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fped.2016.00056\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,30]]},"references-count":83,"URL":"https:\/\/doi.org\/10.3389\/fped.2016.00056","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,30]]}}}